JP2015519137A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015519137A5 JP2015519137A5 JP2015514591A JP2015514591A JP2015519137A5 JP 2015519137 A5 JP2015519137 A5 JP 2015519137A5 JP 2015514591 A JP2015514591 A JP 2015514591A JP 2015514591 A JP2015514591 A JP 2015514591A JP 2015519137 A5 JP2015519137 A5 JP 2015519137A5
- Authority
- JP
- Japan
- Prior art keywords
- mat
- fibers
- wound
- gel
- wound dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000835 fiber Substances 0.000 claims description 61
- 208000027418 Wounds and injury Diseases 0.000 claims description 56
- 206010052428 Wound Diseases 0.000 claims description 55
- 239000004332 silver Substances 0.000 claims description 37
- 229910052709 silver Inorganic materials 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 12
- 239000004753 textile Substances 0.000 claims description 9
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 238000004080 punching Methods 0.000 claims description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 21
- -1 silver ions Chemical class 0.000 description 15
- 230000036571 hydration Effects 0.000 description 12
- 238000006703 hydration reaction Methods 0.000 description 12
- 230000000845 anti-microbial effect Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 210000000416 exudates and transudate Anatomy 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 229920000433 Lyocell Polymers 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 239000004599 antimicrobial Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002334 Spandex Polymers 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 238000007385 chemical modification Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000004759 spandex Substances 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000009960 carding Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 229960003600 silver sulfadiazine Drugs 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000011281 clinical therapy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940048368 flamazine Drugs 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000310 rehydration solution Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229940099261 silvadene Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1209745.7 | 2012-05-31 | ||
| GB201209745A GB201209745D0 (en) | 2012-05-31 | 2012-05-31 | Wound dressing |
| PCT/GB2013/051443 WO2013179047A1 (en) | 2012-05-31 | 2013-05-30 | Wound dressing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018116036A Division JP2018187403A (ja) | 2012-05-31 | 2018-06-19 | 創傷包帯 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015519137A JP2015519137A (ja) | 2015-07-09 |
| JP2015519137A5 true JP2015519137A5 (enExample) | 2019-07-11 |
| JP6621328B2 JP6621328B2 (ja) | 2019-12-18 |
Family
ID=46582175
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514591A Active JP6621328B2 (ja) | 2012-05-31 | 2013-05-30 | 創傷被覆材 |
| JP2018116036A Pending JP2018187403A (ja) | 2012-05-31 | 2018-06-19 | 創傷包帯 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018116036A Pending JP2018187403A (ja) | 2012-05-31 | 2018-06-19 | 創傷包帯 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10350326B2 (enExample) |
| EP (2) | EP3750566A1 (enExample) |
| JP (2) | JP6621328B2 (enExample) |
| KR (1) | KR102152480B1 (enExample) |
| CN (1) | CN105007953B (enExample) |
| AU (1) | AU2013269330B2 (enExample) |
| BR (1) | BR112014029931A2 (enExample) |
| CA (1) | CA2875133A1 (enExample) |
| CL (1) | CL2014003240A1 (enExample) |
| DO (1) | DOP2014000275A (enExample) |
| GB (2) | GB201209745D0 (enExample) |
| IL (1) | IL235857A0 (enExample) |
| IN (1) | IN2014DN10234A (enExample) |
| MX (1) | MX355182B (enExample) |
| MY (1) | MY166594A (enExample) |
| NZ (1) | NZ702489A (enExample) |
| PH (1) | PH12014502658A1 (enExample) |
| RU (1) | RU2663457C2 (enExample) |
| SG (1) | SG11201407876TA (enExample) |
| WO (1) | WO2013179047A1 (enExample) |
| ZA (1) | ZA201408742B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
| GB0817796D0 (en) | 2008-09-29 | 2008-11-05 | Convatec Inc | wound dressing |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| US10207031B2 (en) | 2010-12-08 | 2019-02-19 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
| EP2648794B1 (en) | 2010-12-08 | 2019-08-28 | ConvaTec Technologies Inc. | Wound exudate system accessory |
| DK2648795T3 (da) | 2010-12-08 | 2023-03-27 | Convatec Technologies Inc | System til fjernelse af eksudater fra en sårposition |
| GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
| GB2497406A (en) | 2011-11-29 | 2013-06-12 | Webtec Converting Llc | Dressing with a perforated binder layer |
| GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
| GB201209745D0 (en) | 2012-05-31 | 2012-07-18 | Convatec Technologies Inc | Wound dressing |
| JP2016507663A (ja) | 2012-12-20 | 2016-03-10 | コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ | 化学修飾セルロース系繊維の加工 |
| GB2543544A (en) | 2015-10-21 | 2017-04-26 | Brightwake Ltd | Wound dressing |
| KR20190008199A (ko) | 2016-03-30 | 2019-01-23 | 시노보 게엠베하 | 상처에서 미생물 감염의 검출 방법 |
| WO2017173069A1 (en) | 2016-03-30 | 2017-10-05 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
| GB201608099D0 (en) | 2016-05-09 | 2016-06-22 | Convatec Technologies Inc | Negative pressure wound dressing |
| MX2019000232A (es) | 2016-07-08 | 2019-11-12 | Convatec Technologies Inc | Deteccion de flujo de fluidos. |
| BR112019000284A2 (pt) | 2016-07-08 | 2019-04-16 | Convatec Technologies Inc. | aparelho de coleta de fluido |
| CA3030152A1 (en) | 2016-07-08 | 2018-01-11 | Convatec Technologies Inc. | Flexible negative pressure system |
| CN114601631A (zh) * | 2017-07-11 | 2022-06-10 | 佛山市优特医疗科技有限公司 | 一种加强的伤口敷料及其制备方法 |
| GB2568101B (en) * | 2017-11-06 | 2022-09-07 | Brightwake Ltd | Antimicrobial dressing |
| HUE067442T2 (hu) | 2017-11-09 | 2024-10-28 | Convatec Technologies Inc | Sztómafigyelõ rendszer |
| EP3710074B1 (en) | 2017-11-16 | 2024-03-20 | ConvaTec Limited | Fluid collection apparatus |
| AU2019335512A1 (en) * | 2018-09-06 | 2021-03-18 | Convatec Technologies Inc. | Adaptable adhesive wound dressings |
| USD893514S1 (en) | 2018-11-08 | 2020-08-18 | 11 Health And Technologies Limited | Display screen or portion thereof with graphical user interface |
| WO2020245656A1 (en) | 2019-06-03 | 2020-12-10 | Convatec Limited | Methods and devices to disrupt and contain pathogens |
| GB201912076D0 (en) * | 2019-08-22 | 2019-10-09 | Smith & Nephew | Absorbent component |
| US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
| US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
| AU2021213463A1 (en) * | 2020-01-29 | 2022-07-21 | Convatec Limited | A pump assembly and a wound therapy apparatus |
| JP2023545504A (ja) | 2020-10-15 | 2023-10-30 | コンバテック・テクノロジーズ・インコーポレイテッド | オストミーシステムおよび方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE455466C (sv) * | 1986-03-10 | 1993-07-05 | Moelnlycke Ab | Foerband foer vaetskande saar |
| GB9126193D0 (en) | 1991-12-10 | 1992-02-12 | Courtaulds Plc | Cellulosic fibres |
| KR100320636B1 (ko) | 1993-01-22 | 2002-07-27 | 아코디스 스페셜리티 파이버스 리미티드 | 환부보호대 |
| EP2036581B1 (en) | 1998-07-01 | 2012-06-27 | ConvaTec Limited | Wound dressings and materials suitable for use therein |
| CA2268344A1 (en) * | 1999-04-19 | 2000-10-19 | Texel Inc. | Three dimensional needled non-woven absorbent composites |
| US20030191442A1 (en) * | 2000-08-11 | 2003-10-09 | The Procter & Gamble Company | Topsheet for contacting hydrous body tissues and absorbent device with such a topsheet |
| CN1487952A (zh) | 2000-11-28 | 2004-04-07 | �ɶ����＼��ʵ���� | 具有血管活性肠肽的生物学活性的用于治疗肺动脉和小动脉高压的化合物 |
| PT1343510E (pt) * | 2000-11-29 | 2010-07-15 | Convatec Technologies Inc | MATERIAIS ANTIMICROBIANOS ESTáVEIS LUZ |
| GB0115276D0 (en) * | 2001-06-22 | 2001-08-15 | Univ Leeds | Fabrics |
| GB2377177A (en) | 2001-07-05 | 2003-01-08 | Acordis Speciality Fibres Ltd | Wound dressing comprising gel forming and superabsorbent layers |
| JP4448093B2 (ja) * | 2002-12-31 | 2010-04-07 | ベーエスエヌ・メディカル・ゲーエムベーハー | 創傷包帯 |
| EP1610830A1 (en) * | 2003-03-28 | 2006-01-04 | Coloplast A/S | A wound dressing |
| CN1833731A (zh) * | 2005-03-17 | 2006-09-20 | 李毅彬 | 一种抗菌医用敷料的制造方法及其用途 |
| GB0513552D0 (en) | 2005-07-01 | 2005-08-10 | Bristol Myers Squibb Co | Bandage |
| KR100788997B1 (ko) * | 2006-03-10 | 2007-12-28 | 김주영 | 은이 화학 결합된 항균성 습윤 드레싱재 제조방법 및 그습윤 드레싱재 |
| JP5037603B2 (ja) * | 2006-04-10 | 2012-10-03 | エシコン・インコーポレイテッド | 強化された吸収性で多層の止血用創傷手当て用品および製造方法 |
| US20080113574A1 (en) * | 2006-11-14 | 2008-05-15 | Neron Rene B | Wound care product made from bulked filament tow |
| JP2009000858A (ja) * | 2007-06-20 | 2009-01-08 | Unitika Ltd | 不燃性積層不織布 |
| GB0805162D0 (en) | 2008-03-19 | 2008-04-23 | Bristol Myers Squibb Co | Antibacterial wound dressing |
| GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
| US20100030170A1 (en) * | 2008-08-01 | 2010-02-04 | Keith Alan Keller | Absorptive Pad |
| GB2464970A (en) | 2008-11-01 | 2010-05-05 | Christian Stephenson | Wound dressing comprising fibrous plugs |
| US9221963B2 (en) | 2008-11-27 | 2015-12-29 | Speciality Fibres And Materials Ltd. | Absorbent material |
| GB201209745D0 (en) | 2012-05-31 | 2012-07-18 | Convatec Technologies Inc | Wound dressing |
-
2012
- 2012-05-31 GB GB201209745A patent/GB201209745D0/en not_active Ceased
-
2013
- 2013-05-30 IN IN10234DEN2014 patent/IN2014DN10234A/en unknown
- 2013-05-30 SG SG11201407876TA patent/SG11201407876TA/en unknown
- 2013-05-30 EP EP20189013.4A patent/EP3750566A1/en not_active Withdrawn
- 2013-05-30 CA CA 2875133 patent/CA2875133A1/en not_active Abandoned
- 2013-05-30 AU AU2013269330A patent/AU2013269330B2/en active Active
- 2013-05-30 JP JP2015514591A patent/JP6621328B2/ja active Active
- 2013-05-30 RU RU2014153900A patent/RU2663457C2/ru not_active IP Right Cessation
- 2013-05-30 NZ NZ702489A patent/NZ702489A/en not_active IP Right Cessation
- 2013-05-30 US US14/403,954 patent/US10350326B2/en active Active
- 2013-05-30 EP EP13726839.7A patent/EP2854881B1/en active Active
- 2013-05-30 BR BR112014029931A patent/BR112014029931A2/pt not_active Application Discontinuation
- 2013-05-30 WO PCT/GB2013/051443 patent/WO2013179047A1/en not_active Ceased
- 2013-05-30 KR KR1020147036277A patent/KR102152480B1/ko not_active Expired - Fee Related
- 2013-05-30 GB GB1421899.4A patent/GB2517620B/en active Active
- 2013-05-30 MX MX2014014377A patent/MX355182B/es active IP Right Grant
- 2013-05-30 CN CN201380028751.8A patent/CN105007953B/zh active Active
- 2013-05-30 MY MYPI2014003333A patent/MY166594A/en unknown
-
2014
- 2014-11-23 IL IL235857A patent/IL235857A0/en unknown
- 2014-11-27 ZA ZA2014/08742A patent/ZA201408742B/en unknown
- 2014-11-28 CL CL2014003240A patent/CL2014003240A1/es unknown
- 2014-11-28 DO DO2014000275A patent/DOP2014000275A/es unknown
- 2014-11-28 PH PH12014502658A patent/PH12014502658A1/en unknown
-
2018
- 2018-06-19 JP JP2018116036A patent/JP2018187403A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6621328B2 (ja) | 創傷被覆材 | |
| JP2015519137A5 (enExample) | ||
| US11628093B2 (en) | Wound dressing | |
| EP3078360B1 (en) | Wound dressing with three-layer structure and preparation method thereof | |
| US5256477A (en) | Absorbency alginate fabric, use as wound and burn dressings, and a method for its preparation | |
| GB2524510A (en) | Wound dressing | |
| EP3087960A1 (en) | Wound dressing containing three-layer fabric and wound dressing manufacturing method | |
| WO2005018543A2 (en) | Silver-containing wound care device, composition therefor, and method of producing | |
| CN107469131A (zh) | 一种海藻酸钙生物复合医用敷料及其制备方法 | |
| CN104958135A (zh) | 海藻酸盐混纺纱布 | |
| WO2012098298A1 (en) | Anti-microbial wound dressing and a method of producing the same | |
| KR20220093484A (ko) | 항균 및 지혈성을 가지는 복합드레싱재 | |
| KR20180091145A (ko) | 키토산을 포함하는 의료용 섬유 구조체 및 그 제조방법 | |
| RU90328U1 (ru) | Полотно нетканое атравматическое | |
| KR20250152408A (ko) | 항균 및 지혈성을 가지는 복합드레싱재 | |
| CN109966053A (zh) | 一种芦荟创可贴 |